{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T16:20:13Z","timestamp":1700583613091},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2003,6,16]],"date-time":"2003-06-16T00:00:00Z","timestamp":1055721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,6,16]],"date-time":"2003-06-16T00:00:00Z","timestamp":1055721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2003,7,1]]},"DOI":"10.1038\/sj.gt.3301972","type":"journal-article","created":{"date-parts":[[2003,6,13]],"date-time":"2003-06-13T16:38:20Z","timestamp":1055522300000},"page":"1129-1134","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["In vivo characterization of a prostate-specific antigen promoter-based suicide gene therapy for the treatment of benign prostatic hyperplasia"],"prefix":"10.1038","volume":"10","author":[{"given":"H S","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H Y","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y H","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J H","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D G","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J J","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,6,16]]},"reference":[{"key":"BF3301972_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/canjclin.46.1.5","volume":"46","author":"SH Parker","year":"1996","unstructured":"Parker SH, Tong T, Bolden S, Wingo PA . Cancer statistics 1996. CA Cancer J Clin 1996; 46: 5\u201327.","journal-title":"CA Cancer J Clin"},{"key":"BF3301972_CR2","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/S0022-5347(17)35229-1","volume":"151","author":"PP Saginer","year":"1994","unstructured":"Saginer PP et al. Results of an epidemiological survey using a modified American Urological Association Symptom Index for benign prostatic hyperplasia in France. J Urol 1994; 151: 1266\u20131270","journal-title":"J Urol"},{"key":"BF3301972_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0022-5347(17)35405-8","volume":"150","author":"CG Chute","year":"1993","unstructured":"Chute CG et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993; 150: 85\u201389.","journal-title":"J Urol"},{"key":"BF3301972_CR4","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/S0022-5347(17)41174-8","volume":"141","author":"TA Stamey","year":"1989","unstructured":"Stamey TA, Kabalin JN . Prostatic specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients. J Urol 1989; 141: 1070\u20131075.","journal-title":"J Urol"},{"key":"BF3301972_CR5","first-page":"334","volume":"60","author":"JP Latham","year":"2000","unstructured":"Latham JP, Searle PF, Mautner V, James ND . Prostate-specific antigen promoter\/enhancer driven gene therapy for prostatic cancer: construction and testing of tissue-specific adenovirus vector. Cancer Res 2000; 60: 334\u2013341.","journal-title":"Cancer Res"},{"key":"BF3301972_CR6","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1089\/hum.1998.9.11-1617","volume":"9","author":"R Martiniello-Wilks","year":"1998","unstructured":"Martiniello-Wilks R et al. In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy system delivered by identical adenovirus vectors. Hum Gene Ther 1998; 9: 1617\u20131626.","journal-title":"Hum Gene Ther"},{"key":"BF3301972_CR7","first-page":"5276","volume":"46","author":"FL Moolten","year":"1986","unstructured":"Moolten FL . Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46: 5276\u20135281.","journal-title":"Cancer Res"},{"key":"BF3301972_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/jnci\/82.4.297","volume":"84","author":"FL Moolten","year":"1990","unstructured":"Moolten FL, Wells JM . Curability of tumors bearing herpes simplex thymidine kinase gene transferred by retroviral vectors. J Natl Cancer Inst 1990; 84: 297\u2013300.","journal-title":"J Natl Cancer Inst"},{"key":"BF3301972_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s003450050184","volume":"18","author":"M Shalev","year":"2000","unstructured":"Shalev M et al. Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpes virus thymidine kinase gene. World J Urol 2000; 18: 125\u2013129.","journal-title":"World J Urol"},{"key":"BF3301972_CR10","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/S0022-5347(05)67534-9","volume":"163","author":"M Shalev","year":"2000","unstructured":"Shalev M et al. Suicide gene therapy toxicity after multiple and repeat in patients with localized prostate cancer. J Urol 2000; 163: 1747\u20131750.","journal-title":"J Urol"},{"key":"BF3301972_CR11","first-page":"2024","volume":"55","author":"M Feng","year":"1995","unstructured":"Feng M et al. Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme. Cancer Res 1995; 55: 2024\u20132028.","journal-title":"Cancer Res"},{"key":"BF3301972_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/BF02789331","volume":"3","author":"FL Graham","year":"1995","unstructured":"Graham FL, Prevec L . Methods for construction of adenovirus vectors. Mol Biotechnol 1995; 3: 207\u2013220.","journal-title":"Mol Biotechnol"},{"key":"BF3301972_CR13","first-page":"2245","volume":"56","author":"HJ Xu","year":"1996","unstructured":"Xu HJ et al. Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein. Cancer Res 1996; 56: 2245\u20132249.","journal-title":"Cancer Res"},{"key":"BF3301972_CR14","first-page":"1697","volume":"4","author":"JW Rocco","year":"1998","unstructured":"Rocco JW et al. P16\/INK4A adenovirus-mediated gene therapy for human head and neck squamous cancer cell. Clin Cancer Res 1998; 4: 1697\u20131704.","journal-title":"Clin Cancer Res"},{"key":"BF3301972_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/030098589002700507","volume":"27","author":"LA Lowseth","year":"1990","unstructured":"Lowseth LA, Gerlach RF, Gillett NA, Muggenburg BA . Age-related changes in the prostate and testes of the beagle dog. Vet Pathol 1990; 27: 347\u2013353.","journal-title":"Vet Pathol"},{"key":"BF3301972_CR16","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/sj.cgt.7700065","volume":"6","author":"MS Steiner","year":"1999","unstructured":"Steiner MS, Zhang Y, Carraher J, Lu Y . In vivo expression of prostate-specific adenovirus vectors in a canine model. Cancer Gene Ther 1999; 6: 456\u2013464.","journal-title":"Cancer Gene Ther"},{"key":"BF3301972_CR17","first-page":"962","volume":"53","author":"RG Vile","year":"1993","unstructured":"Vile RG, Hart IR . In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res 1993; 53: 962\u2013967.","journal-title":"Cancer Res"},{"key":"BF3301972_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1089\/hum.1994.5.2-175","volume":"5","author":"P Macri","year":"1994","unstructured":"Macri P, Gordon JW . Delayed morbidity and mortality of albumin\/SV 40 T-antigen transgenic mice after insertion of an alpha-fetoprotein\/herpes virus thymidine kinase transgene and treatment with gancyclovir. Hum Gene Ther 1994; 5:175\u2013182.","journal-title":"Hum Gene Ther"},{"key":"BF3301972_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/sj.cgt.7700011","volume":"6","author":"Y Lu","year":"19199","unstructured":"Lu Y et al. Delivery of adenoviral vectors to the prostate for gene therapy. Cancer Gene Ther 199; 6: 64\u201372.","journal-title":"Cancer Gene Ther"},{"key":"BF3301972_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s003450050180","volume":"18","author":"Y Lu","year":"2000","unstructured":"Lu Y, Steiner MS . Transcriptionally regulated adenoviruses for prostate-specific gene therapy. World J Urol 2000; 18: 93\u2013101.","journal-title":"World J Urol"},{"key":"BF3301972_CR21","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1073\/pnas.83.10.3166","volume":"83","author":"KW Watt","year":"1986","unstructured":"Watt KW et al. Human prostate-specific antigen: structure and functional similarity with serine proteases. Proc Natl Acad Sci USA 1986; 83: 3166\u20133170.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301972_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/pros.2990110207","volume":"11","author":"M McEntee","year":"1987","unstructured":"McEntee M, Isaacs W, Smith C . Adenocarcinoma of canine prostate: immunohistochemical examination for secretory antigens. Prostate 1987; 11: 163\u2013170.","journal-title":"Prostate"},{"key":"BF3301972_CR23","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1089\/hum.1995.6.11-1417","volume":"6","author":"S Pang","year":"1995","unstructured":"Pang S et al. Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer. Hum Gene Ther 1995; 6: 1417\u20131426.","journal-title":"Hum Gene Ther"},{"key":"BF3301972_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0022-5347(01)63094-5","volume":"160","author":"A Gotoh","year":"1998","unstructured":"Gotoh A et al. Deveolpment of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer. J Urol 1998; 160: 220\u2013229.","journal-title":"J Urol"},{"key":"BF3301972_CR25","first-page":"85","volume":"3","author":"AA Elshami","year":"1996","unstructured":"Elshami AA et al. Gap junctions play a role in the \u2018bystander effect\u2019 of the herpes simplex virus thymidine kinase\/gancyclovir sytem in vitro. Gene Therapy 1996; 3: 85\u201392.","journal-title":"Gene Therapy"},{"key":"BF3301972_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1089\/hum.1993.4.6-725","volume":"4","author":"WL Bi","year":"1993","unstructured":"Bi WL, Parysek LM, Warnick R, Stambrrok PL . In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV-TK retroviral gene therapy. Hum Gene Ther 1993; 4: 725\u2013731.","journal-title":"Hum Gene Ther"},{"key":"BF3301972_CR27","first-page":"506","volume":"39","author":"MJ Perez-Cruet","year":"1994","unstructured":"Perez-Cruet MJ et al. Adenovirus-mediated gene therapy of experimental gliomas. J Neurosci 1994; 39: 506\u2013511.","journal-title":"J Neurosci"},{"key":"BF3301972_CR28","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1089\/10430349950018229","volume":"10","author":"JR Herman","year":"1999","unstructured":"Herman JR et al. In situ gene therapy for adenocarcinoma of the prostate a phase I clinical trial. Hum Gene Ther 1999; 10: 1239\u20131249.","journal-title":"Hum Gene Ther"},{"key":"BF3301972_CR29","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/sj.gt.3300477","volume":"4","author":"JY Park","year":"1997","unstructured":"Park JY et al. Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase\/gancyclovir mediated gene therapy. Gene Therapy 1997; 4: 909\u2013917.","journal-title":"Gene Therapy"},{"key":"BF3301972_CR30","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1089\/hum.1998.9.16-2385","volume":"9","author":"RL Touraine","year":"1998","unstructured":"Touraine RL et al. Enhancement of the herpes simplex virus thymidine kinase\/gancyclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions. Hum Gene Ther 1998; 9: 2385\u20132391.","journal-title":"Hum Gene Ther"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3301972.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301972","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301972.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T02:27:19Z","timestamp":1648607239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3301972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,16]]},"references-count":30,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2003,7,1]]}},"alternative-id":["BF3301972"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3301972","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,16]]},"assertion":[{"value":"5 December 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}